Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Saliva contains various cells, proteins, and molecules, and it is emerging as a material for diagnosing various diseases. Syndecan-1 (SDC-1) is a member of cell surface heparan sulfate proteoglycans and is mainly expressed in epithelial cells and plasma cells. SDC-1 is known to be associated with various cancers and inflammatory response, but there are few studies related to the change of SDC-1 levels in the saliva and plasma of healthy individuals due to aging process.
Methods: The study was conducted on 61 females who were healthy without any metabolic diseases, systemic infection, and oral cavity lesions. The subjects were divided into two groups based on age. Those below 40 years were placed in Group I and those who were 40 years and above were placed in Group II. Saliva was collected according to the guideline and the salivary flow rate (SFR) was determined. SDC-1 levels in the plasma and saliva were measured using a commercially available sandwich ELISA method.
Results: Age was significantly different between Group I and II (28.0 ± 2.5 vs. 47.4 ± 5.5, p < 0.001). SFR also showed a significant difference between Group I and II [0.32 (0.13 - 0.39) vs. 0.25 (0.16 - 0.35) ng/mL, p = 0.003]. Salivary SDC-1 level in Group I was significantly higher than that in Group II (p < 0.001). In addition, plasma SDC-1 level in Group I was also higher than that in Group II (p < 0.001). SFR was not significantly correlated as age increased, but it showed a significant negative correlation with salivary SDC-1 (r = -0.607, p < 0.001) and plasma SDC-1 levels (r = -0.373, p = 0.003). Salivary SDC-1 level was significantly correlated with plasma SDC-1 level (r = 0.331, p = 0.012).
Conclusions: In the younger group, the SFR, salivary, and plasma SDC-1 levels were significantly higher than in the older group. Salivary and plasma SDC-1 showed significant negative correlation as age increased. Although this study was not conducted on a large scale, it might be thought to provide information on the age-related variation for salivary and plasma SDC-1 levels in the aging process.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.7754/Clin.Lab.2021.210113 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Endothelial dysfunction in areas of unburned skin in a burn injury model.
Burns
July 2025
Firefighters' Burn and Surgical Research Laboratory, MedStar Health Research Institute, Washington, DC, United States; Departments of Surgery and Biochemistry, Georgetown University School of Medicine, Washington, DC, United States; The Burn Center, MedStar Washington Hospital Center, Washington, DC
Introduction: Burn shock is mediated by a complex inflammatory response leading to endothelial cell dysfunction (EnD) and increased vascular permeability in large total body surface area (TBSA) injuries. Smaller TBSA burns do not induce systemic EnD. Previous studies in animal models have examined systemic markers of endothelial cell dysfunction following thermal injury and have aimed to characterize this dysfunction in various end organs.
View Article and Find Full Text PDFYoung first-episode psychosis patients exhibit impaired microvascular function in the skin and low systemic nitric oxide availability, independent of classical cardiovascular risk factors.
Schizophr Res
August 2025
Jagiellonian University, Jagiellonian Centre for Experimental Therapeutics (JCET), 30-348 Krakow, Poland; Jagiellonian University, Jagiellonian University Medical College, Chair of Pharmacology, 31-531 Krakow, Poland. Electronic address:
Impaired endothelial function in patients with psychotic disorders may contribute to increased cardiovascular mortality, but the mechanisms involved remain unclear. Here, we comprehensively analyzed endothelial function in 33 young (median age 18: IQR 17-27) patients diagnosed with first-episode psychosis (FEP), examining large vessels (flow-mediated dilation; FMD) and the microcirculation in peripheral vessels (peripheral arterial tonometry following reactive hyperemia; RH-PAT) and in the skin (flow-mediated skin fluorescence; FMSF). We also measured the plasma concentration of nitric oxide (NO) metabolites (nitrite/nitrate) and 18 biomarkers related to endothelial function, including those representative of glycocalyx damage (SDC-1), endothelial inflammation (sVCAM-1), disrupted endothelial permeability (Angpt-1, Angpt-2), and hemostasis (TAFI, THBS-1).
View Article and Find Full Text PDFTranexamic acid did not attenuate the acute rise in plasma syndecan-1 in a severely injured cohort: a laboratory analysis of the PATCH clinical trial.
Intensive Care Med Exp
July 2025
Intensive Care Services, Royal Brisbane and Women's Hospital, Butterfield St Herston, Brisbane, QLD, 4006, Australia.
Background: Injury to the vascular endothelium occurs in up to 34% of patients acutely following severe traumatic injury and can be quantified clinically by measuring the plasma concentration of syndecan-1 (SDC-1). Tranexamic acid (TXA) attenuates endothelial damage in animal and cell culture models and has been associated with lower SDC-1 levels after prehospital TXA administration. The aim of this study was to assess the association of prehospital TXA on SDC-1 levels in a more severely injured prehospital cohort.
View Article and Find Full Text PDFRBT-1, a "preconditioning" agent, mitigates syndecan-1 shedding in patients undergoing "on pump" cardiac surgery and following experimental AKI.
Physiol Rep
February 2025
Renibus Therapeutics, Southlake, Texas, USA.
During systemic stress, syndecan-1 (SDC-1) shedding into plasma results, implying endothelial damage. RBT-1, a "preconditioning" agent, has been shown to mitigate postoperative complications following cardiac surgeries. This study assessed whether RBT-1 preconditioning attenuated SDC-1 shedding in these patients, implying a vascular protective effect.
View Article and Find Full Text PDFSphingosine-1-Phosphate, a Marker of Endothelial Injury and Disease Severity in Preeclampsia.
Hypertension
May 2025
Division of Obstetrics and Gynecology, Institute of Clinical Sciences Lund (C.E., F.P., L.E., S.R.H.), Lund University, Sweden.
Background: Preeclampsia is a hypertensive pregnancy disorder marked by endothelial damage. Healthy endothelium is covered by a protective glycocalyx layer, which, when degraded, releases detectable products into the blood. Sphingosine-1-phosphate (S1P) is a cardiovascular biomarker involved in glycocalyx preservation, linked to placentation and preeclampsia development.
View Article and Find Full Text PDF